GGrantIndex
← Search

PHASE I STUDY OF INTRATHECAL GEMCITABINE IN PATIENTS WITH REFRACTORY MALIGNANCY

$7,017M01FY2005RRNIH

Baylor College Of Medicine, Houston TX

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →